{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/95481"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/95481","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Macromolecular design for modulation of amyloid fibrillar assembly","abstract":"Amyloid protein aggregation is notorious for its association with many devastating human diseases such as AIDS, cancer, Alzheimer's disease, and prion diseases. Scientists have made significant progress in designing modulators which prevent amyloid formation and provide potential therapeutics for amyloid-related diseases. Recently, extensive studies indicate that the elusive oligomeric intermediates, rather than the most visible amyloid fibrils, are the cause of cytotoxicity in amyloid aggregation. However, the rational design of synthetic modulators that specifically target the toxic oligomer intermediates and regulate the final shape and size of amyloid assemblies remains a challenge. Breakthroughs in this area provide insight and understanding for the toxic oligomer intermediates and the mechanism of amyloid protein aggregation. The fundamental studies on molecular level also provide the potential foundation for promising solutions to investigate amyloid-related diseases. This dissertation describes a new class of rationally designed polymeric modulators which specifically target amyloid β oligomers and control amyloid aggregation. Chapter 2-3 focus on the design of series of polymer-peptide conjugates which redirect Aβ fibrillar assembly by stabilizing Aβ oligomers into structurally well-defined discrete nanostructures. The modulatory effect was achieved by taking advantages of nucleation-dependent mechanism of Aβ aggregation. We investigated the influence of multivalency and specificity of molecular structures and optimized the Aβ modulatory effect by tuning molecular weights of polymers, as well as the loading ratio and the sequences of the attached Aβ recognition peptides. Chapter 4 describes the extended application of polymer-peptide conjugates as fibril breakers to dissociate preformed Aβ fibrils, and the dissociation rate is dependent on the molecular weight of conjugates. Chapter 5 reports the design of polyethylenimine-perphenazine conjugates as dual modulators which accelerate the formation of Aβ prefibrillar intermediates and inhibit the following fibrillation. The above polymeric conjugates are proved to detoxify Aβ oligomers and the results of MTT cell viability assays are summarized in Chapter 6. Our molecular design may thus represent a prototype of multivalent macromolecules that control the amyloid fibrillar assembly via a nucleation-dependent mechanism. It remains to be seen if this design concept is broadly applicable to the control of other molecular self-assembly process.","abstract_html":"Amyloid protein aggregation is notorious for its association with many devastating human diseases such as AIDS, cancer, Alzheimer's disease, and prion diseases. Scientists have made significant progress in designing modulators which prevent amyloid formation and provide potential therapeutics for amyloid-related diseases. Recently, extensive studies indicate that the elusive oligomeric intermediates, rather than the most visible amyloid fibrils, are the cause of cytotoxicity in amyloid aggregation. However, the rational design of synthetic modulators that specifically target the toxic oligomer intermediates and regulate the final shape and size of amyloid assemblies remains a challenge. Breakthroughs in this area provide insight and understanding for the toxic oligomer intermediates and the mechanism of amyloid protein aggregation. The fundamental studies on molecular level also provide the potential foundation for promising solutions to investigate amyloid-related diseases. This dissertation describes a new class of rationally designed polymeric modulators which specifically target amyloid β oligomers and control amyloid aggregation. Chapter 2-3 focus on the design of series of polymer-peptide conjugates which redirect Aβ fibrillar assembly by stabilizing Aβ oligomers into structurally well-defined discrete nanostructures. The modulatory effect was achieved by taking advantages of nucleation-dependent mechanism of Aβ aggregation. We investigated the influence of multivalency and specificity of molecular structures and optimized the Aβ modulatory effect by tuning molecular weights of polymers, as well as the loading ratio and the sequences of the attached Aβ recognition peptides. Chapter 4 describes the extended application of polymer-peptide conjugates as fibril breakers to dissociate preformed Aβ fibrils, and the dissociation rate is dependent on the molecular weight of conjugates. Chapter 5 reports the design of polyethylenimine-perphenazine conjugates as dual modulators which accelerate the formation of Aβ prefibrillar intermediates and inhibit the following fibrillation. The above polymeric conjugates are proved to detoxify Aβ oligomers and the results of MTT cell viability assays are summarized in Chapter 6. Our molecular design may thus represent a prototype of multivalent macromolecules that control the amyloid fibrillar assembly via a nucleation-dependent mechanism. It remains to be seen if this design concept is broadly applicable to the control of other molecular self-assembly process.","abstract_has_math":false,"creators":["Song, Yang"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Moore, Jeffrey S.","Moore, Edwin G","Rienstra, Chad M.","Zimmerman, Steven C.","Murphy, Catherine J."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-03-01T16:36:54Z","date_published":"2017-03-01T16:36:54Z","updated_at":"2026-07-22T22:26:37Z","subjects":["polymer","Alzheimer's disease","self-assembly","protein aggregation","modulation","bioconjugation","amyloid","peptide"],"languages":["en"],"rights":["Copyright 2016 Yang Song"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/95481","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Moore, Jeffrey S.","Moore, Edwin G","Rienstra, Chad M.","Zimmerman, Steven C.","Murphy, Catherine J."]},{"key":"dc:creator","label":"Author","values":["Song, Yang"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-03-01T16:36:54Z","2019-03-02T10:15:07Z","2016-11-28","2016-12"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["polymer","Alzheimer's disease","self-assembly","protein aggregation","modulation","bioconjugation","amyloid","peptide"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2016 Yang Song"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/95481"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Amyloid protein aggregation is notorious for its association with many devastating human diseases such as AIDS, cancer, Alzheimer's disease, and prion diseases. Scientists have made significant progress in designing modulators which prevent amyloid formation and provide potential therapeutics for amyloid-related diseases. Recently, extensive studies indicate that the elusive oligomeric intermediates, rather than the most visible amyloid fibrils, are the cause of cytotoxicity in amyloid aggregation. However, the rational design of synthetic modulators that specifically target the toxic oligomer intermediates and regulate the final shape and size of amyloid assemblies remains a challenge. Breakthroughs in this area provide insight and understanding for the toxic oligomer intermediates and the mechanism of amyloid protein aggregation. The fundamental studies on molecular level also provide the potential foundation for promising solutions to investigate amyloid-related diseases. This dissertation describes a new class of rationally designed polymeric modulators which specifically target amyloid β oligomers and control amyloid aggregation. Chapter 2-3 focus on the design of series of polymer-peptide conjugates which redirect Aβ fibrillar assembly by stabilizing Aβ oligomers into structurally well-defined discrete nanostructures. The modulatory effect was achieved by taking advantages of nucleation-dependent mechanism of Aβ aggregation. We investigated the influence of multivalency and specificity of molecular structures and optimized the Aβ modulatory effect by tuning molecular weights of polymers, as well as the loading ratio and the sequences of the attached Aβ recognition peptides. Chapter 4 describes the extended application of polymer-peptide conjugates as fibril breakers to dissociate preformed Aβ fibrils, and the dissociation rate is dependent on the molecular weight of conjugates. Chapter 5 reports the design of polyethylenimine-perphenazine conjugates as dual modulators which accelerate the formation of Aβ prefibrillar intermediates and inhibit the following fibrillation. The above polymeric conjugates are proved to detoxify Aβ oligomers and the results of MTT cell viability assays are summarized in Chapter 6. Our molecular design may thus represent a prototype of multivalent macromolecules that control the amyloid fibrillar assembly via a nucleation-dependent mechanism. It remains to be seen if this design concept is broadly applicable to the control of other molecular self-assembly process.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2018-12-01","The student, Yang Song, accepted the attached license on 2016-11-22 at 12:00.","The student, Yang Song, submitted this Dissertation for approval on 2016-11-22 at 12:18.","This Dissertation was approved for publication on 2016-11-28 at 12:56.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10298 on 2017-02-28 at 14:36:41","Made available in DSpace on 2017-03-01T16:36:54Z (GMT). No. of bitstreams: 7 SONG-DISSERTATION-2016.pdf: 13483856 bytes, checksum: 45e106a00d9daea3fcf9ec6a9a1311ed (MD5) LICENSE.txt: 4206 bytes, checksum: 2bfe2cd446fdc3fcb4acef91ba747c38 (MD5) PROQUEST_LICENSE.txt: 4552 bytes, checksum: de1566dfaff27c027cc452ccf2d373af (MD5) RightsLink Printable License Figure 1.1.pdf: 61194 bytes, checksum: d5267d6e293fc01501da5a1b122ed48d (MD5) RightsLink Printable License Figure 3.30.pdf: 51484 bytes, checksum: 281171696ffacb6a63aa53faf664357d (MD5) RightsLink Printable License Figure1.4.pdf: 51492 bytes, checksum: 2fc38e41f185ca2dca7b10fcb311a646 (MD5) RightsLink Printable License figure 1.2.pdf: 51460 bytes, checksum: e3adea4c2ae332697121e0f4517553e3 (MD5) Previous issue date: 2016-11-28","Embargo set by: Seth Robbins for item 98597 Lift date: 2019-03-01T16:37:19Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only Restriction Lifted for Item 98597 on 2019-03-02T10:15:07Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Macromolecular design for modulation of amyloid fibrillar assembly"]}]}],"canonical_facts":{"dc:contributor":["Moore, Jeffrey S.","Moore, Edwin G","Rienstra, Chad M.","Zimmerman, Steven C.","Murphy, Catherine J."],"dc:creator":["Song, Yang"],"dc:date":["2017-03-01T16:36:54Z","2019-03-02T10:15:07Z","2016-11-28","2016-12"],"dc:description":["Amyloid protein aggregation is notorious for its association with many devastating human diseases such as AIDS, cancer, Alzheimer's disease, and prion diseases. Scientists have made significant progress in designing modulators which prevent amyloid formation and provide potential therapeutics for amyloid-related diseases. Recently, extensive studies indicate that the elusive oligomeric intermediates, rather than the most visible amyloid fibrils, are the cause of cytotoxicity in amyloid aggregation. However, the rational design of synthetic modulators that specifically target the toxic oligomer intermediates and regulate the final shape and size of amyloid assemblies remains a challenge. Breakthroughs in this area provide insight and understanding for the toxic oligomer intermediates and the mechanism of amyloid protein aggregation. The fundamental studies on molecular level also provide the potential foundation for promising solutions to investigate amyloid-related diseases. This dissertation describes a new class of rationally designed polymeric modulators which specifically target amyloid β oligomers and control amyloid aggregation. Chapter 2-3 focus on the design of series of polymer-peptide conjugates which redirect Aβ fibrillar assembly by stabilizing Aβ oligomers into structurally well-defined discrete nanostructures. The modulatory effect was achieved by taking advantages of nucleation-dependent mechanism of Aβ aggregation. We investigated the influence of multivalency and specificity of molecular structures and optimized the Aβ modulatory effect by tuning molecular weights of polymers, as well as the loading ratio and the sequences of the attached Aβ recognition peptides. Chapter 4 describes the extended application of polymer-peptide conjugates as fibril breakers to dissociate preformed Aβ fibrils, and the dissociation rate is dependent on the molecular weight of conjugates. Chapter 5 reports the design of polyethylenimine-perphenazine conjugates as dual modulators which accelerate the formation of Aβ prefibrillar intermediates and inhibit the following fibrillation. The above polymeric conjugates are proved to detoxify Aβ oligomers and the results of MTT cell viability assays are summarized in Chapter 6. Our molecular design may thus represent a prototype of multivalent macromolecules that control the amyloid fibrillar assembly via a nucleation-dependent mechanism. It remains to be seen if this design concept is broadly applicable to the control of other molecular self-assembly process.","Submission published under a 24 month embargo labeled 'U of I Access', the embargo will last until 2018-12-01","The student, Yang Song, accepted the attached license on 2016-11-22 at 12:00.","The student, Yang Song, submitted this Dissertation for approval on 2016-11-22 at 12:18.","This Dissertation was approved for publication on 2016-11-28 at 12:56.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10298 on 2017-02-28 at 14:36:41","Made available in DSpace on 2017-03-01T16:36:54Z (GMT). No. of bitstreams: 7 SONG-DISSERTATION-2016.pdf: 13483856 bytes, checksum: 45e106a00d9daea3fcf9ec6a9a1311ed (MD5) LICENSE.txt: 4206 bytes, checksum: 2bfe2cd446fdc3fcb4acef91ba747c38 (MD5) PROQUEST_LICENSE.txt: 4552 bytes, checksum: de1566dfaff27c027cc452ccf2d373af (MD5) RightsLink Printable License Figure 1.1.pdf: 61194 bytes, checksum: d5267d6e293fc01501da5a1b122ed48d (MD5) RightsLink Printable License Figure 3.30.pdf: 51484 bytes, checksum: 281171696ffacb6a63aa53faf664357d (MD5) RightsLink Printable License Figure1.4.pdf: 51492 bytes, checksum: 2fc38e41f185ca2dca7b10fcb311a646 (MD5) RightsLink Printable License figure 1.2.pdf: 51460 bytes, checksum: e3adea4c2ae332697121e0f4517553e3 (MD5) Previous issue date: 2016-11-28","Embargo set by: Seth Robbins for item 98597 Lift date: 2019-03-01T16:37:19Z Reason: Author requested U of Illinois access only (OA after 2yrs) in Vireo ETD system","U of I Only Restriction Lifted for Item 98597 on 2019-03-02T10:15:07Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/95481"],"dc:language":["en"],"dc:rights":["Copyright 2016 Yang Song"],"dc:subject":["polymer","Alzheimer's disease","self-assembly","protein aggregation","modulation","bioconjugation","amyloid","peptide"],"dc:title":["Macromolecular design for modulation of amyloid fibrillar assembly"],"dc:type":["text"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:37Z"}